ANGPTL4 promotes the progression of cutaneous melanoma to brain metastasis
Authors:
Open Access
- 5 July 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (44) , 75778-75796
Abstract
In an ongoing effort to identify molecular determinants regulating melanoma brain metastasis, we previously identified Angiopoietin-like 4 (ANGPTL4) as a component of the molecular signature of such metastases.Keywords
This publication has 66 references indexed in Scilit:
- B7-H4(B7x)–Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma PatientsClinical Cancer Research, 2016
- Epigenomic Landscape of Melanoma Progression to Brain Metastasis: Unexplored Therapeutic AlternativesEpigenomics, 2015
- Astrocytes facilitate melanoma brain metastasis via secretion of IL‐23The Journal of Pathology, 2015
- The metastatic microenvironment: Claudin‐1 suppresses the malignant phenotype of melanoma brain metastasisInternational Journal of Cancer, 2014
- The metastatic microenvironment: Brain‐residing melanoma metastasis and dormant micrometastasisInternational Journal of Cancer, 2011
- Chemokine–chemokine receptor axes in melanoma brain metastasisImmunology Letters, 2010
- Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonizationClinical & Experimental Metastasis, 2008
- The treatment of brain metastases in melanoma patientsCancer Treatment Reviews, 2004
- Expression of vascular endothelial growth factor is necessary but not sufficient for production and growth of brain metastasis.2000
- Cerebral metastases of cutaneous melanomaBritish Journal of Cancer, 1997